Lushang Freda Pharmaceutical Co (SHSE:600223) Research & Development: ¥157 Mil (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:600223 Lushang Freda Pharmaceutical Co Ltd SHSE:600223
68 GF Score
Price ¥5.49
GF Value ¥6.56
Valuation Modestly Undervalued
! 2 Warning Signs
View Full Analysis

What is Lushang Freda Pharmaceutical Co Research & Development?

Lushang Freda Pharmaceutical Co SHSE:600223 68 Research & Development is ¥157 Mil as of Mar. 2026. GuruFocus rates SHSE:600223 with a GF Score™ of 68/100 and a GF Value™ of ¥6.56 (Modestly Undervalued). The stock has 2 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Lushang Freda Pharmaceutical Co's Research & Development for the three months ended in Mar. 2026 was ¥37 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was ¥157 Mil.

Lushang Freda Pharmaceutical Co  (SHSE:600223) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Lushang Freda Pharmaceutical Co Research & Development Related Terms

Lushang Freda Pharmaceutical Co Research & Development Historical Data

* Premium members only.

The historical data trend for Lushang Freda Pharmaceutical Co's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Lushang Freda Pharmaceutical Co Research & Development Chart

Lushang Freda Pharmaceutical Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 118.75 133.92 153.37 166.77 161.72

Lushang Freda Pharmaceutical Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 41.79 37.38 36.89 45.66 36.87
SHSE:600223
68GF Score
Lushang Freda Pharmaceutical Co Ltd SHSE:600223
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Lushang Freda Pharmaceutical Co Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥157 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of ¥157 Mil mean?
Lushang Freda Pharmaceutical Co (SHSE:600223) has a Research & Development of ¥157 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on Lushang Freda Pharmaceutical Co and its competitors.
Is Lushang Freda Pharmaceutical Co's Research & Development too high?
Lushang Freda Pharmaceutical Co's current Research & Development is ¥157 Mil. Overall, Lushang Freda Pharmaceutical Co has a GF Score™ of 68/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Lushang Freda Pharmaceutical Co's Research & Development compare to competitors?
Lushang Freda Pharmaceutical Co's Research & Development of ¥157 Mil can be compared against companies in the Real Estate industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Real Estate company?
A good Research & Development depends on the Real Estate industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Lushang Freda Pharmaceutical Co and its competitors. Lushang Freda Pharmaceutical Co's current Research & Development is ¥157 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Lushang Freda Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Lushang Freda Pharmaceutical Co (SHSE:600223) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥6.56, compared to a current price of ¥5.49 — trading 16.3% below its estimated fair value. The current Research & Development is ¥157 Mil. Lushang Freda Pharmaceutical Co's overall GF Score™ is 68/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Lushang Freda Pharmaceutical Co (SHSE:600223), the current Research & Development is ¥157 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Lushang Freda Pharmaceutical Co (SHSE:600223) Overvalued in 2026?

Based on GuruFocus' analysis, Lushang Freda Pharmaceutical Co stock appears to be undervalued. The current stock price of ¥5.49 is trading 16.3% below its estimated GF Value™ of ¥6.56. GuruFocus considers Lushang Freda Pharmaceutical Co to be Modestly Undervalued.

Key valuation signals for SHSE:600223:

  • Research & Development: ¥157 Mil
  • GF Value™: ¥6.56 vs. price of ¥5.49 (16.3% below fair value)
  • GF Score™: 68/100 with 2 warning signs

No single metric tells the full story. See the SHSE:600223 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Lushang Freda Pharmaceutical Co Business Description

Address No. 9777 Jingshi Road, Building 5, Lixia District, Jinan City, CHN
Lushang Freda Pharmaceutical Co Ltd formerly Lushang Health Industry Development Co Ltd is a real estate developer in China. The company is engaged in the development of office buildings, infrastructure, apartments, and hotels.
68GF Score

Get the complete analysis for SHSE:600223

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥5.49
Price
¥6.56
GF Value